461.68
+23.28
+(5.31%)
At close: 4:00:00 PM EST
461.68
0.00
(0.00%)
After hours: 4:53:54 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
ALTSHULER DAVID Officer | Sale | Nov 15, 2024 | 25,813 |
ATKINSON EDWARD MORROW III Chief Technology Officer | Sale | Jun 12, 2024 | 15,972 |
BHATIA SANGEETA N Director | Sale | Aug 30, 2024 | 4,435 |
BILLER JONATHAN PRIM Officer | Sale | Oct 2, 2024 | 16,651 |
BOZIC CARMEN Officer | Sale | Aug 7, 2024 | 23,259 |
KEWALRAMANI RESHMA Chief Executive Officer | Sale | Nov 8, 2024 | 75,772 |
LEIDEN JEFFREY M Officer and Director | Sale | Aug 30, 2024 | 10,434 |
SACHDEV AMIT Officer | Stock Gift | Jun 5, 2024 | -- |
SACHS BRUCE I Director | Sale | Aug 1, 2024 | 40,000 |
WAGNER CHARLES F JR Chief Financial Officer | Sale | Nov 11, 2024 | 44,137 |
Related Tickers
REGN Regeneron Pharmaceuticals, Inc.
672.98
-1.48%
CRSP CRISPR Therapeutics AG
41.59
-1.07%
VKTX Viking Therapeutics, Inc.
32.75
-2.79%
ALNY Alnylam Pharmaceuticals, Inc.
271.31
-2.11%
AXSM Axsome Therapeutics, Inc.
106.46
-2.20%
MDGL Madrigal Pharmaceuticals, Inc.
334.80
-1.03%
NTLA Intellia Therapeutics, Inc.
10.32
-1.81%
MRNA Moderna, Inc.
39.42
-3.95%
SRPT Sarepta Therapeutics, Inc.
113.72
-0.64%
AKRO Akero Therapeutics, Inc.
54.08
-2.31%